A result of 50 ery/µL (erythrocytes per microliter) on a urine test means red blood cells are present in your urine at a level above normal, and it warrants attention but is not, by itself, a reason to panic. Automated urine analyzers report red blood cells in this unit, and while a completely normal sample typically shows fewer than about 5 ery/µL, a reading of 50 sits in a gray zone where the cause could be anything from a hard workout to a urinary tract infection to, less commonly, something that needs more investigation. What matters far more than the number alone is the context: your age, symptoms, medications, and whether the finding repeats on a second test.
What the Number on Your Report Actually Measures
Most modern labs use automated flow-cytometry analyzers to count cells in urine. These machines pass a stream of urine through a laser and count individual red blood cells, reporting the result as ery/µL. This is a different unit from the older method, where a technician looks at urine under a microscope and counts red blood cells per high-power field (RBC/HPF). The two measurements do not convert neatly into each other, but as a rough guide, the commonly used clinical threshold for microscopic blood in urine is about 3 RBC/HPF on microscopy, and automated analyzers set their own reference ranges, usually flagging anything above roughly 5 to 25 ery/µL depending on the lab. At 50 ery/µL, your result is above most labs’ normal cutoff, so the report will typically say the finding is abnormal.
One study comparing the Sysmex automated analyzer with traditional microscopy found that the automated approach had a sensitivity of 83% and specificity of 94% for detecting bleeding from the lower urinary tract, while microscopy’s corresponding values were 79% and 90%.1Oxford Academic (Nephrology Dialysis Transplantation). Assessment of haematuria: automated urine flowmetry vs microscopy In practical terms, both methods are good but imperfect, and neither one catches every case or avoids every false alarm. This is why doctors often confirm an abnormal automated result with microscopy before deciding on next steps.
Why the Result Might Not Reflect What Is Actually Happening
Urine dipsticks and automated analyzers are screening tools, not final answers. A number of things can push a reading up or down without any true bleeding being present.
One well-documented issue is vitamin C. If you take supplements or eat a large amount of vitamin C-rich food before your test, ascorbic acid in the urine can interfere with the chemical reaction on a dipstick, causing a false-negative result for blood. A multicenter study found that when vitamin C was present in urine, about 10.6% of hemoglobin dipstick results were falsely negative.2PubMed Central. The influence of vitamin C on the urine dipstick tests in the clinical specimens: a multicenter study Separate testing confirmed that ascorbic acid can interfere with glucose, hemoglobin, nitrite, and bilirubin readings on dipsticks at varying concentrations.3PubMed Central. Ascorbic acid—A black hole of urine chemistry screening So vitamin C can hide blood that is actually there, which is the opposite problem from what most people worry about with a positive result, but it illustrates how sensitive these tests are to outside interference.
Going the other direction, false positives for red blood cells are also possible. An analysis of 2,600 urine samples found that about 22% of the discrepancies between dipstick and microscopic results were false-positive red blood cell readings.4Europe PMC. Discrepancy in results between dipstick urinalysis and urine sediment microscopy Myoglobin from muscle breakdown and free hemoglobin can trigger a positive dipstick for blood even when intact red blood cells are absent. Dehydration, menstrual contamination, and recent sexual activity can also elevate results.
The urine’s acidity matters, too. Research has shown that a urinary pH below 6.0 impairs red blood cell detection in sediment, while specific gravity did not have a significant effect.5PubMed Central. Determination of red blood cells in urinary sediment: Do pH and specific gravity of urine matter? Very acidic urine can lyse (burst) red blood cells before they reach the microscope, so the count underestimates the real level. All of this means a single reading of 50 ery/µL needs to be interpreted carefully, and most guidelines recommend confirming an isolated abnormal result with a repeat test before launching into a full workup.
Exercise-Induced Hematuria
If you gave a urine sample within a day or two of intense exercise, that alone could explain the result. Running, cycling, swimming, and even vigorous weightlifting can produce blood in the urine through a combination of direct bladder trauma (the bladder wall slapping against itself when partially empty), increased filtration pressure in the kidneys, and micro-injury to the urinary tract. A study of post-exercise hematuria found that about 81% of participants cleared their blood in urine within three days, and most of the remainder cleared within a week.6PubMed. Post exertional hematuria The research also found that the appearance of blood was more closely related to the intensity of exercise than to how long it lasted.
The same study identified a useful cutoff: if blood in the urine persists beyond two weeks after exercise stops, it is unlikely to be exercise-related, and an underlying cause should be investigated. Three individuals in that study whose hematuria lasted beyond 14 days turned out to have kidney disease on biopsy.6PubMed. Post exertional hematuria So if you are an active person and this is a one-off finding, your doctor will probably ask you to repeat the test after resting for 48 to 72 hours.
Infections, Stones, and Prostate Issues
Urinary tract infections are one of the most common reasons for microscopic blood in urine. A bacterial infection irritates and inflames the bladder lining, which can cause small amounts of bleeding. Typical symptoms alongside the blood include frequent urination, urgency, and burning during urination, and the urine may look cloudy or smell different.7Medicine. Urinary tract infection If your 50 ery/µL result came alongside those symptoms and the dipstick also showed nitrites or leukocytes, infection is the leading suspect, and antibiotics should resolve both the symptoms and the blood.
Kidney stones are another frequent cause. As a stone travels through the urinary tract, it scrapes the lining and causes bleeding that can range from invisible to the eye to bright red. The degree of blood often does not correlate neatly with stone size; a tiny stone can cause significant hematuria if it lodges in the right spot.8PubMed Central. Hematuria as a Sign of Kidney Stone Disease Evaluated Using Computed Tomography: A Review Stone-related hematuria usually comes with flank pain or cramping that radiates to the groin, though some stones produce blood with minimal discomfort.
In men, an enlarged prostate (benign prostatic hyperplasia, or BPH) is an underappreciated cause. A retrospective study of 166 men referred for hematuria evaluation found that reassurance alone was sufficient in about a quarter of cases, while about half were started on finasteride, a medication that shrinks the prostate and reduces its blood vessel density.9PubMed Central. Hematuria Secondary to Benign Prostatic Hyperplasia: Retrospective Analysis of 166 Men Identified in a Single One Stop Hematuria Clinic The median age in that cohort was 73, but BPH-related hematuria can occur earlier, especially in men who already have urinary symptoms like a weak stream or nighttime bathroom trips.
When Doctors Look for Kidney Disease
If the blood in your urine appears to come from the kidneys rather than the bladder or lower tract, the evaluation takes a different direction. One clue is the shape of the red blood cells under the microscope. Red blood cells that squeeze through damaged glomeruli (the kidney’s tiny filtering units) become distorted, and a particular shape called an acanthocyte is especially telling. Research on biopsy-proven glomerulonephritis found that when acanthocytes made up 5% or more of the red blood cells in urine, the specificity for glomerular disease was 98%, meaning it almost never showed up by coincidence in people without kidney problems.10Kidney International. Acanthocyturia—A characteristic marker for glomerular bleeding The sensitivity was lower, at 52%, so a normal red cell shape does not rule out glomerular disease, but a positive finding is a strong signal.
IgA nephropathy is one of the most common glomerular diseases worldwide and a classic cause of persistent or recurrent microscopic hematuria. It tends to flare during or shortly after upper respiratory infections, and patients often present with hematuria that comes and goes over months or years.11PubMed Central. IgA nephropathy Another condition, thin basement membrane disease, can produce lifelong microscopic hematuria that remains entirely benign in most people. However, because distinguishing thin basement membrane disease from early forms of more serious kidney disease is difficult, long-term follow-up is advised even when the initial prognosis looks favorable.12Kidney International. The width of the basement membrane does not influence clinical presentation or outcome of thin glomerular basement membrane disease with persistent hematuria
The Cancer Question
This is the concern that keeps people up at night after seeing an abnormal result. The honest answer is that cancer is found in a relatively small minority of people investigated for microscopic blood in urine, but the risk is not zero, and certain factors raise it meaningfully.
A large study of people with microscopic hematuria found an overall three-year urinary tract cancer incidence of 0.68%. Being over 40, male, and having higher red blood cell counts all increased the risk.13PubMed. Association of hematuria on microscopic urinalysis and risk of urinary tract cancer A separate cohort study of 2,630 patients found that about 2% had a urinary tract neoplasm detected, with age 50 and older and a history of visible blood in the urine being the strongest predictors.14Mayo Clinic Proceedings. Stratifying Risk of Urinary Tract Malignant Tumors in Patients With Asymptomatic Microscopic Hematuria Among people who had specific symptoms or risk factors, the rate was higher: a study of over 1,100 patients with asymptomatic hematuria referred for evaluation found that roughly one in five had bladder cancer, though that cohort was heavily selected and included many with visible blood, smoking history, and advanced age.15PubMed Central. Accurate Risk Assessment of Patients with Asymptomatic Hematuria for the Presence of Bladder Cancer Smoking was a powerful independent predictor in that study, with roughly a fourfold increase in the odds of bladder cancer for people with any smoking history.
To put those numbers in perspective: if you are under 40, have never smoked, and have no other symptoms, the probability that 50 ery/µL on a single test reflects cancer is very low. If you are over 50 with a decades-long smoking history, the same number on a repeat test deserves prompt evaluation.
How Doctors Stratify Risk and Decide on Testing
The American Urological Association and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (AUA/SUFU) published a guideline that sorts patients with microscopic hematuria into low-, intermediate-, and high-risk groups for urinary tract cancer.16PubMed. Microhematuria: AUA/SUFU Guideline The categories take into account age, sex, smoking and occupational exposure, the degree of blood on microscopy, whether blood persists on repeat testing, and any history of visible hematuria. This guideline was updated in 2025 with a revised risk stratification system and new guidance on follow-up.17PubMed. Updates to Microhematuria: AUA/SUFU Guideline (2025)
One practical complication is that the risk strata are defined in RBC/HPF from microscopy, using cutoffs of 3–10 (low risk), 11–25 (intermediate risk), and above 25 (high risk).18PubMed. Laboratory Reporting Parameters of Microhematuria: Implications for Interpreting the 2020 AUA Guideline If your lab only reports ery/µL from an automated analyzer, converting to the guideline’s framework is not straightforward, and different labs use different conversion factors. This means your doctor may need to order a manual microscopy count to accurately place you in a risk category. It is worth asking whether your result was from a dipstick, an automated analyzer, or a microscopic count, because the answer changes how confidently anyone can interpret “50.”
What the Workup Looks Like
For patients in the low-risk category, the guideline allows for a repeat urinalysis within six months rather than immediate imaging or procedures. For intermediate- and high-risk patients, the workup typically includes imaging of the upper urinary tract and cystoscopy (a thin camera inserted through the urethra to inspect the bladder lining).
The imaging choice involves a trade-off. CT urography is the most sensitive tool for spotting tumors and stones in the kidneys and ureters, but it delivers a meaningful radiation dose. One analysis estimated an effective radiation dose of about 32 mSv per CT urography and calculated that in a hypothetical population of 100,000 patients with asymptomatic microscopic hematuria, the radiation could cause roughly 149 secondary cancers while detecting an additional 98 cases of upper tract malignancy that ultrasound would have missed.19PubMed. Risk of Radiation from Computerized Tomography Urography in the Evaluation of Asymptomatic Microscopic Hematuria That ratio makes CT urography less clearly beneficial for low-risk patients, which is part of why the guidelines now favor ultrasound as a first-line imaging option for many people, reserving CT for those at higher risk.
Cystoscopy remains the standard for evaluating the bladder directly. A systematic review and meta-analysis of studies where at least 95% of the patients underwent cystoscopy found a pooled bladder cancer detection rate of about 2.7%, rising to roughly 4.6% in high-risk cohorts.20JAMA Network Open. Assessment of Diagnostic Yield of Cystoscopy and Computed Tomographic Urography for Urinary Tract Cancers in Patients Evaluated for Microhematuria: A Systematic Review and Meta-analysis A single-center study of over 2,000 patients undergoing cystoscopy for asymptomatic microscopic hematuria found bladder cancer in 1.2%, all of which were non-muscle-invasive and all in patients over 50.21Urology. The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic Hematuria These numbers explain why younger, lower-risk patients may reasonably be spared the procedure after a shared conversation with their doctor.
Blood Thinners and Other Medications
If you take anticoagulants or antiplatelet medications, you might assume the drug is simply causing or worsening the bleeding and nothing more needs to be done. This is a dangerous assumption. While blood thinners genuinely increase the likelihood of hematuria, they also unmask bleeding from sources that would otherwise stay hidden. A review of unexplained hematuria in patients on direct oral anticoagulants emphasized that hematuria in this setting can carry a remarkably high association with subsequent cancer diagnosis.22PubMed Central. Unexplained hematuria in direct oral anticoagulant use: a single-center retrospective case series In other words, the medication may make a pre-existing tumor bleed enough to show up on a routine test, giving you an earlier warning than you would otherwise get. Current guidelines recommend the same evaluation for patients on anticoagulants as for anyone else with microscopic hematuria.
What Happens If the Workup Finds Nothing
A substantial number of people go through imaging and cystoscopy only to receive reassuringly normal results. Persistent microscopic hematuria with a negative workup is common and, in many cases, traced to thin basement membrane disease, mild IgA nephropathy that does not progress, or low-grade inflammation that never declares itself as a formal disease. The AUA/SUFU guideline recommends periodic follow-up with repeat urinalysis even after a negative evaluation, because a small number of cancers are missed on the initial round and may become detectable later.
For thin basement membrane disease specifically, lifelong monitoring is recommended because a minority of patients who initially appear to have an entirely benign condition go on to develop proteinuria or declining kidney function over decades.12Kidney International. The width of the basement membrane does not influence clinical presentation or outcome of thin glomerular basement membrane disease with persistent hematuria The follow-up is usually straightforward: a urine test and blood pressure check once or twice a year, with more detailed kidney testing if protein appears in the urine or the estimated kidney function starts to drop.
If follow-up urinalyses continue to show blood, your doctor may eventually recommend repeating the workup, particularly if the degree of hematuria increases, if you develop new symptoms, or if you enter a higher-risk age bracket. The interval for repeat evaluation varies by risk group but is typically every one to three years for those with persistent findings. The goal is not to subject you to endless testing but to catch the rare condition that was too small to detect the first time around, while it is still early enough to treat effectively.